Study of Olopatadine HCl Ophthalmic Solutions Compared to Vehicle Using the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis in Japanese Subjects

PHASE3CompletedINTERVENTIONAL

Enrollment

267

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions

Allergic Conjunctivitis

Interventions

DRUG

Olopatadine Hydrochloride Ophthalmic Solution, 0.2%

DRUG

Olopatadine Hydrochloride Ophthalmic Solution, 0.1%

DRUG

Olopatadine 0.2% Vehicle

Inactive ingredients used as placebo comparator

DRUG

Olopatadine 0.1% Vehicle

Inactive ingredients used as placebo comparator